Elizabeth M. Brown
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Elizabeth M. Brown has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
David N. Fisman
3 shared publications- Lisa R. McTaggart
Public Health Laboratories Toronto, Public Health Ontario, Toronto, Ontario, Canada
3 shared publications Susan E. Richardson
3 shared publicationsDonald E. Low
Public Health Laboratories Toronto, Public Health Ontario, Toronto, Ontario, Canada
2 shared publications- Julianne V. Kus
Public Health Ontario
2 shared publications Prasad Rawte
2 shared publications
Latest Publications
- Open Access
- 17 December 2025
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 63 (12) , e0145225
Toxigenic diphtheria rarely detected amid rising cases of nontoxigenic Corynebacterium diphtheriae infections in Ontario, Canada, 2011–2023
Diphtheria remains a major public health threat in areas of the world where diphtheria toxoid-containing vaccine programs are not successfully implemented or maintained. In countries with high vaccine coverage, diphtheria is well-controlled with occasional travel-related cases eliciting a robust public health response to limit transmission. While classic diphtheria is caused by toxigenic Corynebacterium diphtheriae and rarely by other species, such as Corynebacterium ulcerans , infections due to nontoxigenic C. diphtheriae (not covered by the vaccine) are increasingly being reported. We describe the genomic epidemiology of toxigenic and nontoxigenic C. diphtheriae in Ontario, Canada, based on isolates submitted to the Public Health Ontario Laboratory. Of 146 cases, four cases (2.7%) involved toxigenic C. diphtheriae , three of which were associated with travel from endemic countries. Most isolates were nontoxigenic (97.2%) and from cutaneous sources (84.9%), with an increase in submission of nontoxigenic C. diphtheriae isolates from one in 2016 to 65 in 2023. Based on whole-genome sequencing and BIGSdb-Pasteur core genome multi-locus strain typing, most nontoxigenic isolates were categorized into three highly related genetic clusters from sublineages 32 and 76, suggesting epidemiologically linked cases indicative of local transmission. Apart from intermediate susceptibility to penicillin in 98.0% of isolates, antimicrobial resistance was rarely detected. Because infections with nontoxigenic C. diphtheriae are not prevented by vaccination and do not cause classic diphtheria, healthcare professionals should be aware of these trends, given the clinical, public health, and infection control implications when C. diphtheriae is identified in the microbiology laboratory prior to knowledge of toxigenicity. IMPORTANCE: Infections by toxigenic and nontoxigenic Corynebacterium diphtheriae cause vastly different diseases requiring different treatment and public health responses. Healthcare practitioners should be aware of the complexities of diphtheria from a global perspective. Toxigenic C. diphtheriae remains prevalent in regions that do not have well-established vaccination programs, while vaccine hesitancy and compliance issues challenge countries that do require childhood vaccination. These factors, coupled with the propensity for human travel and migration, heighten the risk of cases and outbreaks in non-endemic countries and designate diphtheria as a relevant re-emerging threat. Further complicating public health decisions is the increasing incidence of nontoxigenic C. diphtheriae infections identified among highly vaccinated populations. An excessive public health response in these cases would be burdensome and expensive. Our findings will aid public health departments and hospitals with local risk assessments of the likelihood that a laboratory identification of C. diphtheriae represents a case of toxigenic diphtheria by raising awareness of the disproportionately small number of toxigenic C. diphtheriae recovered from clinical specimens compared to the vast majority of nontoxigenic isolates. Genomic analysis suggests local transmission of nontoxigenic strains, while isolation of toxigenic C. diphtheriae from among a highly vaccinated population remains associated with travel to endemic regions.
- 17 December 2025
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 63 (12) , e0145225
Open AccessToxigenic diphtheria rarely detected amid rising cases of nontoxigenic Corynebacterium diphtheriae infections in Ontario, Canada, 2011–2023
Diphtheria remains a major public health threat in areas of the world where diphtheria toxoid-containing vaccine programs are not successfully implemented or maintained. In countries with high vaccine coverage, diphtheria is well-controlled with occasional travel-related cases eliciting a robust public health response to limit transmission. While classic diphtheria is caused by toxigenic Corynebacterium diphtheriae and rarely by other species, such as Corynebacterium ulcerans , infections due to nontoxigenic C. diphtheriae (not covered by the vaccine) are increasingly being reported. We describe the genomic epidemiology of toxigenic and nontoxigenic C. diphtheriae in Ontario, Canada, based on isolates submitted to the Public Health Ontario Laboratory. Of 146 cases, four cases (2.7%) involved toxigenic C. diphtheriae , three of which were associated with travel from endemic countries. Most isolates were nontoxigenic (97.2%) and from cutaneous sources (84.9%), with an increase in submission of nontoxigenic C. diphtheriae isolates from one in 2016 to 65 in 2023. Based on whole-genome sequencing and BIGSdb-Pasteur core genome multi-locus strain typing, most nontoxigenic isolates were categorized into three highly related genetic clusters from sublineages 32 and 76, suggesting epidemiologically linked cases indicative of local transmission. Apart from intermediate susceptibility to penicillin in 98.0% of isolates, antimicrobial resistance was rarely detected. Because infections with nontoxigenic C. diphtheriae are not prevented by vaccination and do not cause classic diphtheria, healthcare professionals should be aware of these trends, given the clinical, public health, and infection control implications when C. diphtheriae is identified in the microbiology laboratory prior to knowledge of toxigenicity. IMPORTANCE: Infections by toxigenic and nontoxigenic Corynebacterium diphtheriae cause vastly different diseases requiring different treatment and public health responses. Healthcare practitioners should be aware of the complexities of diphtheria from a global perspective. Toxigenic C. diphtheriae remains prevalent in regions that do not have well-established vaccination programs, while vaccine hesitancy and compliance issues challenge countries that do require childhood vaccination. These factors, coupled with the propensity for human travel and migration, heighten the risk of cases and outbreaks in non-endemic countries and designate diphtheria as a relevant re-emerging threat. Further complicating public health decisions is the increasing incidence of nontoxigenic C. diphtheriae infections identified among highly vaccinated populations. An excessive public health response in these cases would be burdensome and expensive. Our findings will aid public health departments and hospitals with local risk assessments of the likelihood that a laboratory identification of C. diphtheriae represents a case of toxigenic diphtheria by raising awareness of the disproportionately small number of toxigenic C. diphtheriae recovered from clinical specimens compared to the vast majority of nontoxigenic isolates. Genomic analysis suggests local transmission of nontoxigenic strains, while isolation of toxigenic C. diphtheriae from among a highly vaccinated population remains associated with travel to endemic regions.
- Open Access
- 1 July 2018
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 24 (7) , 1257-1266
Epidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990–2015
Elevated incidence of blastomycosis in Ontario calls for diagnostic vigilance.
- 1 July 2018
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 24 (7) , 1257-1266
Open AccessEpidemiology and Geographic Distribution of Blastomycosis, Histoplasmosis, and Coccidioidomycosis, Ontario, Canada, 1990–2015
Elevated incidence of blastomycosis in Ontario calls for diagnostic vigilance.
- Open Access
- 18 July 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (7) , e0159396
Phylogeographic Analysis of Blastomyces dermatitidis and Blastomyces gilchristii Reveals an Association with North American Freshwater Drainage Basins
Blastomyces dermatitidis and Blastomyces gilchristii are dimorphic fungal pathogens that cause serious pulmonary and systemic infections in humans. Although their natural habitat is in the environment, little is known about their specific ecologic niche(s). Here, we analyzed 25 microsatellite loci from 169 strains collected from various regions throughout their known endemic range in North America, representing the largest and most geographically diverse collection of isolates studied to date. Genetic analysis of multilocus microsatellite data divided the strains into four populations of B. dermatitidis and four populations of B. gilchristii. B. dermatitidis isolates were recovered from areas throughout North America, while the B. gilchristii strains were restricted to Canada and some northern US states. Furthermore, the populations of both species were associated with major freshwater drainage basins. The four B. dermatitidis populations were partitioned among (1) the Nelson River drainage basin, (2) the St. Lawrence River and northeast Atlantic Ocean Seaboard drainage basins, (3) the Mississippi River System drainage basin, and (4) the Gulf of Mexico Seaboard and southeast Atlantic Ocean Seaboard drainage basins. A similar partitioning of the B. gilchristii populations was observed among the more northerly drainage basins only. These associations suggest that the ecologic niche where the sexual reproduction, growth, and dispersal of B. dermatitidis and B. gilchristii occur is intimately linked to freshwater systems. For most populations, sexual reproduction was rare enough to produce significant linkage disequilibrium among loci but frequent enough that mating-type idiomorphic ratios were not skewed from 1:1. Furthermore, the evolutionary divergence of B. dermatitidis and B. gilchristii was estimated at 1.9 MYA during the Pleistocene epoch. We suggest that repeated glaciations during the Pleistocene period and resulting biotic refugia may have provided the impetus for speciation as theorized for other species associated with temperate freshwater systems.
- 18 July 2016
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 11 (7) , e0159396
Open AccessPhylogeographic Analysis of Blastomyces dermatitidis and Blastomyces gilchristii Reveals an Association with North American Freshwater Drainage Basins
Blastomyces dermatitidis and Blastomyces gilchristii are dimorphic fungal pathogens that cause serious pulmonary and systemic infections in humans. Although their natural habitat is in the environment, little is known about their specific ecologic niche(s). Here, we analyzed 25 microsatellite loci from 169 strains collected from various regions throughout their known endemic range in North America, representing the largest and most geographically diverse collection of isolates studied to date. Genetic analysis of multilocus microsatellite data divided the strains into four populations of B. dermatitidis and four populations of B. gilchristii. B. dermatitidis isolates were recovered from areas throughout North America, while the B. gilchristii strains were restricted to Canada and some northern US states. Furthermore, the populations of both species were associated with major freshwater drainage basins. The four B. dermatitidis populations were partitioned among (1) the Nelson River drainage basin, (2) the St. Lawrence River and northeast Atlantic Ocean Seaboard drainage basins, (3) the Mississippi River System drainage basin, and (4) the Gulf of Mexico Seaboard and southeast Atlantic Ocean Seaboard drainage basins. A similar partitioning of the B. gilchristii populations was observed among the more northerly drainage basins only. These associations suggest that the ecologic niche where the sexual reproduction, growth, and dispersal of B. dermatitidis and B. gilchristii occur is intimately linked to freshwater systems. For most populations, sexual reproduction was rare enough to produce significant linkage disequilibrium among loci but frequent enough that mating-type idiomorphic ratios were not skewed from 1:1. Furthermore, the evolutionary divergence of B. dermatitidis and B. gilchristii was estimated at 1.9 MYA during the Pleistocene epoch. We suggest that repeated glaciations during the Pleistocene period and resulting biotic refugia may have provided the impetus for speciation as theorized for other species associated with temperate freshwater systems.
- 21 July 2014
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 52 (7) , 766-769
Effective method for the heat inactivation of Blastomyces dermatitidis
Manipulation of Blastomyces dermatitidis requires the use of containment level 3 (CL3) practices. However, access to CL3 laboratories is limited and working conditions are restrictive. We describe the validation of a "heat-killing" method to inactivate B. dermatitidis, thus allowing cellular material to be removed from the CL3 laboratory for subsequent DNA isolation that is suitable for genetic applications.
- 21 July 2014
- Published by Oxford University Press (OUP) in Medical Mycology
- Vol. 52 (7) , 766-769
Effective method for the heat inactivation of Blastomyces dermatitidis
Manipulation of Blastomyces dermatitidis requires the use of containment level 3 (CL3) practices. However, access to CL3 laboratories is limited and working conditions are restrictive. We describe the validation of a "heat-killing" method to inactivate B. dermatitidis, thus allowing cellular material to be removed from the CL3 laboratory for subsequent DNA isolation that is suitable for genetic applications.
- Open Access
- 22 March 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (3) , e59237
Phylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp. nov. within the Human Pathogenic Fungus Blastomyces dermatitidis
Analysis of the population genetic structure of microbial species is of fundamental importance to many scientific disciplines because it can identify cryptic species, reveal reproductive mode, and elucidate processes that contribute to pathogen evolution. Here, we examined the population genetic structure and geographic differentiation of the sexual, dimorphic fungus Blastomyces dermatitidis, the causative agent of blastomycosis. Criteria for Genealogical Concordance Phylogenetic Species Recognition (GCPSR) applied to seven nuclear loci (arf6, chs2, drk1, fads, pyrF, tub1, and its-2) from 78 clinical and environmental isolates identified two previously unrecognized phylogenetic species. Four of seven single gene phylogenies examined (chs2, drk1, pyrF, and its-2) supported the separation of Phylogenetic Species 1 (PS1) and Phylogenetic Species 2 (PS2) which were also well differentiated in the concatenated chs2-drk1-fads-pyrF-tub1-arf6-its2 genealogy with all isolates falling into one of two evolutionarily independent lineages. Phylogenetic species were genetically distinct with interspecific divergence 4-fold greater than intraspecific divergence and a high Fst value (0.772, PBlastomyces dermatitidis, which we use to describe a novel species, Blastomyces gilchristii sp. nov. In addition, we discuss the value of population genetic and phylogenetic analyses as a foundation for disease surveillance, understanding pathogen evolution, and discerning phenotypic differences between phylogenetic species.
- 22 March 2013
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (3) , e59237
Open AccessPhylogenetic Analysis Reveals a Cryptic Species Blastomyces gilchristii, sp. nov. within the Human Pathogenic Fungus Blastomyces dermatitidis
Analysis of the population genetic structure of microbial species is of fundamental importance to many scientific disciplines because it can identify cryptic species, reveal reproductive mode, and elucidate processes that contribute to pathogen evolution. Here, we examined the population genetic structure and geographic differentiation of the sexual, dimorphic fungus Blastomyces dermatitidis, the causative agent of blastomycosis. Criteria for Genealogical Concordance Phylogenetic Species Recognition (GCPSR) applied to seven nuclear loci (arf6, chs2, drk1, fads, pyrF, tub1, and its-2) from 78 clinical and environmental isolates identified two previously unrecognized phylogenetic species. Four of seven single gene phylogenies examined (chs2, drk1, pyrF, and its-2) supported the separation of Phylogenetic Species 1 (PS1) and Phylogenetic Species 2 (PS2) which were also well differentiated in the concatenated chs2-drk1-fads-pyrF-tub1-arf6-its2 genealogy with all isolates falling into one of two evolutionarily independent lineages. Phylogenetic species were genetically distinct with interspecific divergence 4-fold greater than intraspecific divergence and a high Fst value (0.772, PBlastomyces dermatitidis, which we use to describe a novel species, Blastomyces gilchristii sp. nov. In addition, we discuss the value of population genetic and phylogenetic analyses as a foundation for disease surveillance, understanding pathogen evolution, and discerning phenotypic differences between phylogenetic species.
- 1 September 2011
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 38 (9) , 811-814
Identification of Sexual Networks Through Molecular Typing of Quinolone-Resistant Neisseria gonorrhoeae in Ontario, Canada
Neisseria gonorrhoeae multi-antigen sequence typing technique demonstrated multiple sexual transmission networks in Ontario, Canada. Isolates with novel sequences had higher odds of originating in Toronto but had no association with heightened population-level quinolone exposure. Neisseria gonorrhoeae multi-antigen sequence typing technique can be a useful tool for investigation of multidrug-resistant N. gonorrhoeae emergence in North America.
- 1 September 2011
- Published by Wolters Kluwer Health in Sexually Transmitted Diseases
- Vol. 38 (9) , 811-814
Identification of Sexual Networks Through Molecular Typing of Quinolone-Resistant Neisseria gonorrhoeae in Ontario, Canada
Neisseria gonorrhoeae multi-antigen sequence typing technique demonstrated multiple sexual transmission networks in Ontario, Canada. Isolates with novel sequences had higher odds of originating in Toronto but had no association with heightened population-level quinolone exposure. Neisseria gonorrhoeae multi-antigen sequence typing technique can be a useful tool for investigation of multidrug-resistant N. gonorrhoeae emergence in North America.
- 1 March 2010
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (3) , 1016-1021
Epidemiology of Invasive Meningococcal Disease with Decreased Susceptibility to Penicillin in Ontario, Canada, 2000 to 2006
Neisseria meningitidis has been relatively slow to acquire resistance to penicillin. We previously reported an increase in the incidence of invasive meningococcal disease (IMD) strains with decreased susceptibility to penicillin (DSP) in Ontario. Our objectives were to evaluate trends in IMD with DSP, to identify case-level predictors of IMD with DSP, and to evaluate the relationship among DSP, bacterial phenotype, and the likelihood of a fatal outcome. All IMD isolates received in Ontario between 2000 and 2006 were submitted to the Public Health Laboratories, Toronto, for confirmation of the species, serogroup determination, and susceptibility testing. Isolates were considered to be IMD strains with DSP if the penicillin MIC was ≥0.125 μg/ml. Temporal trends were evaluated using multivariable Poisson regression models. Correlates of diminished susceptibility and fatal outcome were evaluated with multivariable logistic regression models. The overall rate of IMD caused by strains with DSP in Ontario was approximately 1.20 cases per million population annually (95% confidence interval [95% CI], 0.99 to 1.46). Seventy-nine strains (21.7%) were IMD strains with DSP. There was no year-to-year trend in the incidence of IMD with DSP. IMD with DSP was strongly associated with strains of serogroups Y (odds ratio [OR], 6.3; 95% CI, 3.6 to 11.1) and W-135 (OR, 8.2; 95% CI, 4.0 to 16.7). Infection with serogroup B or C strains was associated with a marked increase in the risk of mortality (OR, 3.07; 95% CI, 1.39 to 6.75); however, no association between IMD with DSP and mortality was observed. In contrast to trends of the 1990s, the incidence of IMD with DSP was stable in Ontario between 2000 and 2006. In Ontario, the serogroup rather than the penicillin MIC is the microbiological parameter most predictive of mortality.
- 1 March 2010
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 54 (3) , 1016-1021
Epidemiology of Invasive Meningococcal Disease with Decreased Susceptibility to Penicillin in Ontario, Canada, 2000 to 2006
Neisseria meningitidis has been relatively slow to acquire resistance to penicillin. We previously reported an increase in the incidence of invasive meningococcal disease (IMD) strains with decreased susceptibility to penicillin (DSP) in Ontario. Our objectives were to evaluate trends in IMD with DSP, to identify case-level predictors of IMD with DSP, and to evaluate the relationship among DSP, bacterial phenotype, and the likelihood of a fatal outcome. All IMD isolates received in Ontario between 2000 and 2006 were submitted to the Public Health Laboratories, Toronto, for confirmation of the species, serogroup determination, and susceptibility testing. Isolates were considered to be IMD strains with DSP if the penicillin MIC was ≥0.125 μg/ml. Temporal trends were evaluated using multivariable Poisson regression models. Correlates of diminished susceptibility and fatal outcome were evaluated with multivariable logistic regression models. The overall rate of IMD caused by strains with DSP in Ontario was approximately 1.20 cases per million population annually (95% confidence interval [95% CI], 0.99 to 1.46). Seventy-nine strains (21.7%) were IMD strains with DSP. There was no year-to-year trend in the incidence of IMD with DSP. IMD with DSP was strongly associated with strains of serogroups Y (odds ratio [OR], 6.3; 95% CI, 3.6 to 11.1) and W-135 (OR, 8.2; 95% CI, 4.0 to 16.7). Infection with serogroup B or C strains was associated with a marked increase in the risk of mortality (OR, 3.07; 95% CI, 1.39 to 6.75); however, no association between IMD with DSP and mortality was observed. In contrast to trends of the 1990s, the incidence of IMD with DSP was stable in Ontario between 2000 and 2006. In Ontario, the serogroup rather than the penicillin MIC is the microbiological parameter most predictive of mortality.